The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Hippo Pathway Activity Influences Liver Cell Fate
Open accessAbstract
The Hippo-signaling pathway is an important regulator of cellular proliferation and organ size. However, little is known about the role of this cascade in the control of cell fate. Employing a combination of lineage tracing, clonal analysis, and organoid culture approaches, we demonstrate that Hippo pathway activity is essential for the maintenance of the differentiated hepatocyte state. Remarkably, acute inactivation of Hippo pathway signaling in vivo is sufficient to dedifferentiate, at very high efficiencies, adult hepatocytes into cells bearing progenitor characteristics. These hepatocyte-derived progenitor cells demonstrate self-renewal and engraftment capacity at the single-cell level. We also identify the NOTCH-signaling pathway as a functional important effector downstream of the Hippo transducer YAP. Our findings uncover a potent role for Hippo/YAP signaling in controlling liver cell fate and reveal an unprecedented level of phenotypic plasticity in mature hepatocytes, which has implications for the understanding and manipulation of liver regeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following diverse injuries, often involving cholestasis, YAP signalling also drives hepatocyte reprogramming via SOX9 induction.”
From Distinct hepatocyte identities in liver homeostasis and regeneration (2023) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These reprogrammed zone 1 hepatocytes exhibited reduced metabolic function, upregulated tissue stem cell markers and increased proliferative capacity, contributing to regeneration.59,60,100,101”
From Distinct hepatocyte identities in liver homeostasis and regeneration (2023) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Acute YAP overexpression results in hepatocyte reprogramming into BEC10.”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“YAP, the main transducer of the Hippo pathway, has been reported to be necessary and sufficient for hepatocyte reprogramming into ductal cells10,11.”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, increased chromatin accessibility near YAP target genes suggested a pivotal role for YAP/TEAD signaling in the reprogramming process (Figure S1C), supporting previous data10.”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Under physiological conditions, activation of YAP is necessary and sufficient to not only reprogram hepatocytes but to precisely control developmental outcomes, organ size and tissue repair10,16,40,41.”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lineage-tracing studies in animal models have confirmed that hepatocytes contribute to bile duct remodeling following cholangiocyte injury10,43–48”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In periportal injury, LPLCs are mainly generated in the region 1-5 layers away from injured bile ducts.[7][8][9]12,13”
From Kupffer-cell-derived IL-6 is repurposed for hepatocyte dedifferentiation via activating progenitor genes from injury-specific enhancers (2023) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, YAP promotes SRY-box transcription factor 9 (SOX9) expression in hepatocytes59 and may confer the hybrid hepatocyte-biliary identity of periportal SOX9+ hepatocytes.60”
From Distinct hepatocyte identities in liver homeostasis and regeneration (2023) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“Hepatocytes display remarkable plasticity and under some conditions can transdifferentiate into BECs, epithelial cells of the bile ducts with completely different morphology, gene expression and function59,[97], [98], [99]”
From Distinct hepatocyte identities in liver homeostasis and regeneration (2023) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“Even at this later stage, reprogrammed hepatocytes maintained distinct chromatin accessibility compared to BECs (Figure 1H), despite resembling them morphologically and transcriptionally10 (Figure S1E).”
From HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury (2025) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“only very recent studies using a mosaic YAP1 induction model have shown that nuclear YAP1 is able to induce hepatocyte dedifferentiation into clonogenic progenitors in vivo (Yimlamai et al., 2014).”
From Hippo Signaling Influences HNF4A and FOXA2 Enhancer Switching during Hepatocyte Differentiation (2014) · cites this paper as Yimlamai et al., 2014
In the citing paper
“Further experiments in mice have shown that hepatocytes can change into a biliary ductular phenotype21, 22 then later re-differentiate into hepatocytes23.”
From Hepatic progenitor cells of biliary origin with liver repopulation capacity (2015) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Model-Based Clustering, Discriminant Analysis, and Density Estimation
Fraley, C., & Raftery, A. E. (2002) · Journal of the American Statistical Association · doi:10.1198/016214502760047131 · Cited by 4,274
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
Huch, M., Dorrell, C., Boj, S. F., van Es, J. H., Li, V. S. W., van de Wetering, M., Sato, T., Hamer, K., Sasaki, N., Finegold, M. J., et al. (2013) · Nature · doi:10.1038/nature11826 · Cited by 1,555
YAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252
Self-citationZhou, D., Conrad, C. H., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W. E., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 937
Furuyama, K., Kawaguchi, Y., Akiyama, H., Horiguchi, M., Kodama, S., Kuhara, T., Hosokawa, S., Elbahrawy, A., Soeda, T., Koizumi, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.722 · Cited by 841
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804
Hamaratoǧlu, F., Willecke, M., Kango‐Singh, M., Nolo, R. M., Hyun, E., Tao, C., Jafar‐Nejad, H., & Halder, G. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1339 · Cited by 765
Cited by
Sorted by citations
Items 401–500 of 846
Zhou, Z., Tan, C., Chau, M. H. K., Jiang, X., Ke, Z., Chen, X., Cao, Y., Kwok, Y. K. Y., Bellgard, M., Leung, T. Y., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac978 · Cited by 29
Neuronal TRPV1-CGRP axis regulates bone defect repair through Hippo signaling pathway
Jiang, Y., Zhu, Z., Wang, B., Yuan, Y., Zhang, Q., Li, Y., Du, Y., & Gong, P. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110779 · Cited by 26
Vondráček, J., & Machala, M. (2016) · Stem Cells International · doi:10.1155/2016/4326194 · Cited by 27
The role of epigenomic alterations in furan-induced hepatobiliary pathologies
de Conti, A., Beland, F. A., & Pogribny, I. P. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.07.049 · Cited by 26
Experimental evaluation of liver regeneration patterns and liver function following ALPPS
Shi, J., Hammarström, C. L., Grzyb, K., & Line, P. (2017) · BJS Open · doi:10.1002/bjs5.18 · Cited by 26
The Role of Mst1 in Lymphocyte Homeostasis and Function
Cheng, J., Jing, Y., Kang, D., Yang, L., Li, J., Yu, Z., Peng, Z., Li, X., Wei, Y., Gong, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00149 · Cited by 27
Pek, N. M. Q., Liu, K. J., Nichane, M., & Ang, L. T. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.09.016 · Cited by 25
Epigenetic Regulation of Cell-Fate Changes That Determine Adult Liver Regeneration After Injury
Aloia, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.643055 · Cited by 25
Hepatocyte generation in liver homeostasis, repair, and regeneration
Pu, W., & Zhou, B. (2022) · Cell Regeneration · doi:10.1186/s13619-021-00101-8 · Cited by 25
Shiode, Y., Kodama, T., Shigeno, S., Murai, K., Tanaka, S., Newberg, J. Y., Kondo, J., Kobayashi, S., Yamada, R., Hikita, H., et al. (2022) · Hepatology · doi:10.1002/hep.32317 · Cited by 25
Liu, W., Ren, L., Wang, T., Navarro–Álvarez, N., & Tang, L. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.15715 · Cited by 25
Jokela, T. A., & LaBarge, M. A. (2021) · Current Stem Cell Reports · doi:10.1007/s40778-020-00182-2 · Cited by 24
YAP transcriptionally regulates ErbB2 to promote liver cell proliferation
Wang, E. Y., Cheng, J.-C., Thakur, A., Yi, Y., Tsai, S.-H., & Hoodless, P. A. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.07.004 · Cited by 24
You, Y., Zhang, X., Wang, X., Yue, D., Meng, F., Zhu, J., Wang, Y., & Sun, X. (2020) · Journal of Immunology Research · doi:10.1155/2020/5018975 · Cited by 24
de Conti, A., Tryndyak, V., Doerge, D. R., Beland, F. A., & Pogribny, I. P. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.06.027 · Cited by 24
YAP-mediated trophoblast dysfunction: the common pathway underlying pregnancy complications
Lin, Q., Cao, J., Yu, J., Zhu, Y., Shen, Y., Wang, S., Wang, Y., Liu, Z., & Chang, Y. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01371-2 · Cited by 23
The phenotypic changes of Schwann cells promote the functional repair of nerve injury
Liao, S., Chen, Y., Luo, Y., Zhang, M., & Min, J. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102438 · Cited by 23
Microenvironmental control of the ductular reaction: balancing repair and disease progression
Sorrentino, G. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07590-4 · Cited by 26
YAP Non-cell-autonomously Promotes Pluripotency Induction in Mouse Cells
Hartman, A. A., Scalf, S. M., Zhang, J., Hu, X., Chen, X., Eastman, A. E., Yang, C. L.-H., & Guo, S. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.006 · Cited by 24
Allegra, A., Pioggia, G., Innao, V., Musolino, C., & Gangemi, S. (2021) · Cancers · doi:10.3390/cancers13081981 · Cited by 23
Shao, C., Jing, Y., Zhao, S., Yang, X. F., Hu, Y., Meng, Y., Huang, Y., Ye, F., Gao, L., Liu, W., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-022-04715-x · Cited by 23
Gromowski, T., Lukacs‐Kornek, V., & Cisowski, J. (2023) · Cancer Cell International · doi:10.1186/s12935-022-02843-0 · Cited by 25
Advances in hepatic stem/progenitor cell biology
Verhulst, S., Best, J., van Grunsven, L. A., & Dollé, L. (2015) · PubMed Central · doi:10.17179/excli2014-576 · Cited by 23
Molecular regulation of mammalian hepatic architecture
Huppert, S. S., & Iwafuchi, M. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.12.003 · Cited by 26
Michalopoulos, G. K. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch45 · Cited by 25
Signalling pathways and transcriptional regulators orchestrating liver development and cancer
Campbell, S. A., Stephan, T. L., Lotto, J., Cullum, R., Drissler, S., & Hoodless, P. A. (2021) · Development · doi:10.1242/dev.199814 · Cited by 22
Wang, H., Wang, R., Huang, D. A., Li, S., Gao, B.-B., Kang, Z., Tang, B., Xie, J., Yan, F., Liang, R., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.592071 · Cited by 22
Decoding YAP dependent transcription in the liver
Biagioni, F., Croci, O., Sberna, S., Donato, E., Sabò, A., Bisso, A., Curti, L., Chiesa, A., & Campaner, S. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac624 · Cited by 22
Eckert, C., Kim, Y. O., Julich‐Haertel, H., Heier, E.-C., Klein, N., Krause, E., Tschernig, T., Kornek, M., Lammert, F., Schuppan, D., et al. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00344.2015 · Cited by 22
Hippo vs. Crab: tissue‐specific functions of the mammalian Hippo pathway
Nishio, M., Maehama, T., Goto, H., Nakatani, K., Kato, W., Omori, H., Miyachi, Y., Togashi, H., Shimono, Y., & Suzuki, A. (2017) · Genes to Cells · doi:10.1111/gtc.12461 · Cited by 22
Concurrent activation of growth factor and nutrient arms of mTORC1 induces oxidative liver injury
Cho, C., Kowalsky, A. H., Namkoong, S., Park, S.-R., Wu, S. A., Kim, B. Y., James, A., Gu, B., Semple, I. A., Tohamy, M. A., et al. (2019) · Cell Discovery · doi:10.1038/s41421-019-0131-9 · Cited by 22
Myofibroblast induces hepatocyte-to-ductal metaplasia via laminin–ɑvβ6 integrin in liver fibrosis
Xu, T., Lu, Z., Xiao, Z., Liu, F., Chen, Y., Wang, Z., Zhu, S., & Song, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2372-9 · Cited by 22
Generation of liver bipotential organoids with a small-molecule cocktail
Wang, X., Ni, C., Jiang, N., Wei, J., Liang, J., Zhao, B. T., & Lin, X. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa010 · Cited by 22
Oxytocin promotes hepatic regeneration in elderly mice
Luo, D., Jin, B., Zhai, X., Li, J., Liu, C., Guo, W., & Li, J. (2021) · iScience · doi:10.1016/j.isci.2021.102125 · Cited by 24
MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer
Lee, N., Kim, S. J., & Hyun, J. (2021) · Biomedicines · doi:10.3390/biomedicines9040347 · Cited by 23
Cell-Based Regeneration and Treatment of Liver Diseases
Hofmann, J. D., Hackl, V., Esser, H., Mészáros, A., Fodor, M., Öfner, D., Troppmair, J., Schneeberger, S., & Hautz, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910276 · Cited by 22
Ye, B., Yue, M., Hu, C., Sun, C., Shao, Y., Jin, Q., Zhang, C., & Yu, G. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10177-5 · Cited by 19
Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis
Hu, Y., Yang, B., Xiao, C., Yang, X., Zhang, H., Yang, P., Du, X., Zhang, G., Liang, B., Bai, N., et al. (2026) · Cell · doi:10.1016/j.cell.2026.02.001 · Cited by 25
Jiang, N., Zhao, L., Zong, D., Yin, L., Wu, L., Chen, C. Y., Song, X., Zhang, Q., Jiang, X., He, X., et al. (2021) · Bioengineered · doi:10.1080/21655979.2021.2001952 · Cited by 21
Ko, S., Kim, M., Molina, L. M., Sirica, A. E., & Monga, S. P. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2022.02.003 · Cited by 21
A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors
Mao, W., Zhou, J., Hu, J., Zhao, K., Fu, Z., Wang, J., & Mao, K. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.969070 · Cited by 21
SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors
Qian, H., Ding, C., Liu, F., Chen, S., Huang, C., Xiao, M., Hong, X.-L., Wang, M., Yan, F., Ding, K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01805-4 · Cited by 21
Cyclopeptide RA-V Inhibits Organ Enlargement and Tumorigenesis Induced by YAP Activation
Ji, X., Song, L., Li, S., Gao, A., Zhao, Y., Han, S., Zhang, Y., Zhu, C., Zhao, S., Wang, Z., et al. (2018) · Cancers · doi:10.3390/cancers10110449 · Cited by 21
Role of the extracellular matrix and YAP/TAZ in cell reprogramming
Liu, L., Liu, M., Xie, D., Liu, X., & Yan, H. (2021) · Differentiation · doi:10.1016/j.diff.2021.11.001 · Cited by 20
Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
Moon, H., Park, H., Min, J., Choi, H., Kim, D. Y., & Ro, S. (2021) · BMC Cancer · doi:10.1186/s12885-022-09516-1 · Cited by 19
DNA methylation in cell plasticity and malignant transformation in liver diseases
Kim, M., Delgado, E. R., & Ko, S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108334 · Cited by 20
Oncogenic MORC2 in cancer development and beyond
Zhang, S., Guo, A., Wang, H., Liu, J., Dong, C., Ren, J., & Wang, G. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.05.010 · Cited by 20
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
Schiavoni, G., Messina, B., Scalera, S., Memeo, L., Colarossi, C., Mare, M., Blandino, G., Ciliberto, G., Bon, G., & Maugeri‐Saccà, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05027-8 · Cited by 20
Fan, S., Gao, Y., Zhao, P., Xie, G., Zhou, Y., Xiao, Y., Li, X., Zhang, S., Gonzalez, F. J., Qu, A., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.030 · Cited by 20
Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
Lin, K. C., Park, H. W., & Guan, K. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050202 · Cited by 20
Manzano‐Núñez, F., Arámbul-Anthony, M. J., Albiñana, A. G., Leal‐Tassias, A., Umanzor, C. A., Gascó, I. B., Herrera, A., Vila, J. F., Burks, D. J., & Noon, L. A. (2019) · PLoS Biology · doi:10.1371/journal.pbio.2006972 · Cited by 20
Xu, M., Wang, J., Xu, Z., Li, R., Wang, P., Shang, R., Cigliano, A., Ribback, S., Solinas, A., Pes, G. M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3750 · Cited by 20
YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways
Zhu, T., Ma, Z., Wang, H., Jia, X., Wu, Y., Fu, L., Li, Z., Zhang, C., & Yu, G. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03866-9 · Cited by 20
Loss ofAnks6leads to YAP deficiency and liver abnormalities
Airik, M., Schüler, M., McCourt, B. T., Weiss, A., Herdman, N., Lüdtke, T. H., Widmeier, E., Stolz, D. B., Nejak‐Bowen, K. N., Yimlamai, D., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa197 · Cited by 21
Self-citationKim, C.-L., Shin, Y.-S., Choi, S.-H., Oh, S., Kim, K., Jeong, H.-S., & Mo, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5619761 · Cited by 20
Chen, Y., Tang, D., Wu, H., Wu, Y., Yuan, T., Zhang, H., Jiao, Y., Yu, W., & Yan, H. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03050-y · Cited by 20
Hippo-YAP signaling in digestive system tumors.
Yin, F., Dong, J., Kang, L., & Liu, X. (2021) · PubMed Central · Cited by 20
Morphogenesis of liver epithelial cells
Tanimizu, N., & Mitaka, T. (2016) · Hepatology Research · doi:10.1111/hepr.12654 · Cited by 21
Yim, S. Y., Shim, J., Shin, J., Jeong, Y. S., Kang, S., Kim, S.-B., Eun, Y., Lee, D. J., Conner, E. A., Factor, V. M., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0313 · Cited by 20
Li, R., & Huang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021666 · Cited by 19
Chi, K. Y., Kim, G., Kim, H., Kim, H., Jo, S., Lee, J., Lee, Y., Yoon, H., Cho, S.-H., Kim, J., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122898 · Cited by 19
Molecular Survey of Cell Source Usage during Subtotal Hepatectomy-Induced Liver Regeneration in Rats
Elchaninov, A. V., Fatkhudinov, T., Usman, N. Y., Kananykhina, E. Y., Arutyunyan, I. V., Макаров, А. В., Bolshakova, G. B., Goldshtein, D. V., & Sukhikh, G. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162613 · Cited by 19
Phosphorylated Ezrin (Thr567) Regulates Hippo Pathway and Yes-Associated Protein (Yap) in Liver
Xue, Y., Bhushan, B., Mars, W. M., Bowen, W. C., Tao, J., Orr, A. V., Stoops, J. W., Yu, Y., Luo, J., Duncan, A. W., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.03.014 · Cited by 19
Sox9EGFP Defines Biliary Epithelial Heterogeneity Downstream of Yap Activity
Tulasi, D. Y., Castaneda, D. M., Wager, K., Hogan, C. B., Alcedo, K. P., Raab, J. R., & Gracz, A. D. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.009 · Cited by 20
Hrncir, H. R., Hantelys, F., & Gracz, A. D. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.02.012 · Cited by 19
Human papillomaviruses: Knowns, mysteries, and unchartered territories
Gelbard, M. K., & Münger, K. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29191 · Cited by 18
Lin, M., Zheng, X., Yan, J., Huang, F., Chen, Y., Ding, R., Wan, J., Zhang, L., Wang, C., Pan, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49045-y · Cited by 20
Cell competition in primary and metastatic colorectal cancer
van Luyk, M. E., García, A. K., Λάμπρου, Μ., & Suijkerbuijk, S. J. E. (2024) · Oncogenesis · doi:10.1038/s41389-024-00530-5 · Cited by 20
HAX-1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation.
Wang, Y., Huo, X., Cao, Z., Xu, H., Zhu, J., Qian, L., Fu, H., & Xu, B. (2015) · PubMed Central · Cited by 18
Abe, M., Yoshida, T., Akiba, J., Ikezono, Y., Wada, F., Masuda, A., Sakaue, T., Tanaka, T., Iwamoto, H., Nakamura, T., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i37.6833 · Cited by 18
Nishio, M., Miyachi, Y., Otani, J., Tane, S., Omori, H., Ueda, F., Togashi, H., Sasaki, T., Mak, T. W., Nakao, K., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802005r · Cited by 19
Li, M., Tang, Y., Gong, Y., Cheng, W., Li, H., Kong, F.-E., Zhu, W., Liu, S., Huang, L., Guan, X., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6041-2 · Cited by 18
How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme
Sanati, M., Aminyavari, S., Mollazadeh, H., Bibak, B., Mohtashami, E., & Afshari, A. R. (2022) · Pharmacological Reports · doi:10.1007/s43440-021-00349-6 · Cited by 18
Shibahara, J., Hayashi, A., Misumi, K., Sakamoto, Y., Arita, J., Hasegawa, K., Kokudo, N., & Fukayama, M. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000579 · Cited by 19
You, Y., Zhang, X., Wang, X., Yue, D., Meng, F., Zhu, J., Wang, Y., & Sun, X. (2021) · Journal of Immunology Research · doi:10.1155/2021/9843489 · Cited by 18
Arnold, F., Mahaddalkar, P. U., Kraus, J. M., Zhong, X., Bergmann, W., Srinivasan, D., Gout, J., Roger, E., Beutel, A. K., Zizer, E., et al. (2021) · Advanced Science · doi:10.1002/advs.202100626 · Cited by 18
Xu, Y., Feng, Y., Zou, R., Yuan, F., & Yuan, Y. (2022) · Cell Biology International · doi:10.1002/cbin.11809 · Cited by 17
Intestinal precursors avoid being misinduced to liver cells by activating Cdx-Wnt inhibition cascade
Yang, Y., Li, Y., Fu, J., Li, Y., Li, S., Ni, R., Yang, Q., & Luo, L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205110119 · Cited by 17
Introducing STRaNDs: shuttling transcriptional regulators that are non-DNA binding
Lu, M. M., Muers, M. R., & Lü, X. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.41 · Cited by 18
Uchida, Y., Ferdousi, F., Zheng, Y., Oda, T., & Isoda, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.578036 · Cited by 17
Poudel, S., Paine‐Cabrera, D., Bhushan, B., Manley, M. W., Gunewardena, S., Jaeschke, H., & Apte, U. M. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab115 · Cited by 17
Clinical translation of liver regeneration therapies: A conceptual road map
Greenbaum, L. E., Ukomadu, C., & Tchorz, J. S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113847 · Cited by 17
Xu, S., Liu, Y., Hu, R., Wang, M., Stöhr, O., Xiong, Y., Chen, L., Kang, H., Zheng, L., Cai, S., et al. (2021) · eLife · doi:10.7554/elife.57462 · Cited by 17
Fate tracing of hepatocytes in mouse liver
Gu, X., Huang, D., Ci, L., Shi, J., Zhang, M., Yang, H., Wang, Z., Sheng, Z., Sun, R., & Fei, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-15973-7 · Cited by 16
The hippo signaling pathway: implications for heart regeneration and disease
Re, D. P. D. (2014) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0027-0 · Cited by 16
Hydrostatic Pressure Controls Angiogenesis Through Endothelial YAP1 During Lung Regeneration
Mammoto, T., Hunyenyiwa, T., Kyi, P., Hendee, K., Matus, K., Rao, S., Lee, S. H., Tabima, D. M., Chesler, N. C., & Mammoto, A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.823642 · Cited by 16
Miura, S., Horisawa, K., Iwamori, T., Tsujino, S., Inoue, K., Karasawa, S., Yamamoto, J., Ohkawa, Y., Sekiya, S., & Suzuki, A. (2024) · Nature Communications · doi:10.1038/s41467-024-47869-2 · Cited by 16
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Lee, N. Y., Choi, M. G., Lee, E. J., & Koo, J. H. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01501-5 · Cited by 17
Ruess, D. A., Probst, M., Marjanović, G., Wittel, U. A., Hopt, U. T., Keck, T., & Bausch, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161233 · Cited by 16
He, W., You, Y., Du, S., Lei, T., Wang, H., Li, X., He, X., Tong, R., & Wang, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9708 · Cited by 17
Liu, Y., Lu, T., Zhang, C., Xue, Z., Xu, J., Busuttil, R. W., Xia, Q., Xu, N., Kupiec‐Weglinski, J. W., & Ji, H. (2019) · Transplantation · doi:10.1097/tp.0000000000002742 · Cited by 16
Yoshii, D., Shimata, K., Yokouchi, Y., Komohara, Y., Suda, H., Honda, M., Yamamura, K., Hibi, T., & Inomata, Y. (2022) · Human Cell · doi:10.1007/s13577-022-00683-8 · Cited by 16
Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy
Kong, D.-L., Zhao, Y.-C., Men, T., & Teng, C.-B. (2015) · Journal of drug targeting (Print) · doi:10.3109/1061186x.2014.983522 · Cited by 16
Liver Regeneration in the Acute Liver Failure Patient
Wirth, K. M., Kizy, S., & Steer, C. J. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.01.004 · Cited by 16
Arisaka, Y., & Yui, N. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36646 · Cited by 16
Zhu, Q., Li, Y., Dong, X., Yang, Y., Wang, H., & Guo, S. (2019) · Oncology Letters · doi:10.3892/ol.2019.11071 · Cited by 16
The discovery, function, and regulation of epithelial splicing regulatory proteins (ESRP) 1 and 2
Derham, J. M., & Kalsotra, A. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221124 · Cited by 16
Generation and characterization of mature hepatocyte organoids for liver metabolic studies
Liu, Y., Zhou, Y., Ahodantin, J., Jin, Y., Zhu, J., Sun, Z., Wu, X., Su, L., & Yang, Y. (2024) · Journal of Cell Science · doi:10.1242/jcs.261961 · Cited by 17
Immune targeting of cancer stem cells in gastrointestinal oncology.
Canter, R. J., Grossenbacher, S. K., Ames, E., & Murphy, W. J. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.066 · Cited by 15
Zhao, Y., Chen, E., Huang, K., Xie, Z., Zhang, S., Wu, D., Ji, F., Zhu, D., Xu, X., & Li, L. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00493 · Cited by 15
Metadata
- Authors
- Yimlamai, D., Christodoulou, C., Galli, G. G., Yanger, K., Pepe-Mooney, B., Gurung, B., Shrestha, K., Cahan, P., Stanger, B. Z., & Camargo, F. D.
- Affiliations
- Boston Children's Hospital (US)
- University of Pennsylvania (US)
- Corresponding author
- Camargo, Fernando D.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 157
- Issue
- 6
- Pages
- 1324-1338
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4136468
- OpenAlex
- W2028593002
- Cited by
- 857
- References
- 48
- Citations by year
- 2026: 34 · 2025: 52 · 2024: 62 · 2023: 64 · 2022: 94 · 2021: 82 · 2020: 91 · 2019: 80 · 2018: 79 · 2017: 58 · 2016: 82 · 2015: 57 · 2014: 20
- FWCI
- 36.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (AR064036, DK083355, DK099559)
- American-Italian Cancer Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases (5T32 DK007477-27)
- National Science Foundation (DGE1144152)
- U.S. Department of Defense (W81XWH-9)
- Harvard Stem Cell Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- Hippo signaling pathway, YAP, hepatocyte dedifferentiation, hepatic progenitor cells, Notch signaling, phenotypic plasticity, liver regeneration, hepatocyte differentiation
- MeSH terms
- Hippo Signaling Pathway, YAP-Signaling Proteins, Animals, Liver, Phosphoproteins, Stem Cells, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Hepatocytes, Adaptor Proteins, Signal Transducing, Mice, Receptors, Notch, Cell Dedifferentiation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
